Humaneva Inc. has entered into a significant investment agreement with Viking Global Investors, a global investment firm based in the United States (“Viking”). Under this agreement, Viking acquired a minority stake in Humaneva Inc., a spin-off of NEUCA S.A, for $50M. In addition, Viking has been granted a one-year option to invest an additional $50M in Humaneva Inc. Humaneva Inc., the parent company of Pratia, Kapadi, and Hyggio – leaders in providing integrated clinical trial solutions – aims to accelerate the evolution of its business model. As a prominent player in the European market, the Group is now setting its sights on expanding into the American and APAC regions, both recognized as hubs for advanced clinical trial activities.
Read the full article: Humaneva Group Secures Major US Private Equity Investment to Accelerate Global Clinical Research Market Expansion //
Source: https://www.accesswire.com/924305/humaneva-group-secures-major-us-private-equity-investment-to-accelerate-global-clinical-research-market-expansion